On December 16, 2020, the FDA approved margetuximab-cmkb (MARGENZA®, MacroGenics) in combination with chemotherapy, for the treatment of patients with metastatic...
Treatment options for breast cancer brain metastases (BCBM) have historically included only surgery, radiation, and limited clinical trial access. However, due to...
A circulating tumor cell (CTC) test is a blood test that looks for tumor cells that were shed from a tumor and are now moving (circulating) through the...
In clinical trials, a washout period describes the length of time that someone enrolled in a trial must not receive any treatment before receiving the...
Listening to podcasts can help you feel connected to your communities, especially during the social isolation of the current pandemic. This month we highlight two...
Next-generation sequencing (NGS) is not the name of a specific breast cancer test. Instead, it is a category of tests that look for all the genomic mutations in a...
Which therapy to use for the first, second or third line of treatment for metastatic breast cancer is again under investigation because new therapies have become...
“Lines of therapy” is the term used to describe the order in which different therapies are given to people as their disease progresses. In practice,...
As our community knows, the COVID-19 pandemic greatly affected all aspects of breast cancer care, including clinical trials. Yet, with your support, we have been...